Trial Profile
A Phase 1, Open-label Study to Determine the Safety, Tolerability, and Pharmacokinetics of Multiple Subcutaneous Doses of Pentosan Polysulfate Sodium (PPS) in Healthy Adult Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2021
Price :
$35
*
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Osteoarthritis; Pain
- Focus Pharmacokinetics
- Sponsors Paradigm Biopharma
- 23 Jun 2021 Status changed from recruiting to completed.
- 13 Oct 2020 Status changed from not yet recruiting to recruiting.
- 20 Aug 2020 New trial record